Title : Development and Characterization of Solid Dispersion of Rasagilline Mesylate for Improvement of Dissolution Rate Using Hydrophilic Carriers

Vol 6 No 6 (2023): Volume 06 Issue 06 June 2023

Article Date Published : 9 June 2023 | Page No.: 3223-3239 | Google Scholar | Crossref doi for this article

Abstract :

The aim of present study was to improve the solubility of Rasagilline mesylate, an Atypical Antipsychotic agent which is BCS Class III drug and thus has very low solubility and hence very poor bioavailability owing to less absorption. Moreover Rasagilline mesylate has a bitter taste. Thus in the present study an attempt was made to taste mask the bitter taste of drug and improve oral bioavailability of drug by formulating the drug into solid dispersion and then formulate the solid dispersions into Fast Dissolving Tablets. Solid Dispersions of Rasagilline mesylate were formulated using various polymers like Plasdone K30, plasdone K90, Eudragit RS100, Eudragit RL 100, Poloxamer 188 and Soluplus in different ratios viz., 1:1 and 1:2 by solvent evaporation method and evaluated for various physicochemical parameters. On the basis of evaluation parameters Solid Dispersion containing Drug : Soluplus :: 1 : 2 was optimized batch having Solubility 1.91 mg/ml, Drug content 102.75 % and % CDR of 98.43 % at 35 mins. For formulating Fast Dissolving Tablets, 32 factorial designs was applied where the batch SD12 and Concentration of Chitosan were taken as dependent variable X1 and X2, respectively and wetting time (sec.) and in vitro disintegration time (sec.) and % CDR were taken as an independent variables. All the formulation prepared by applying experimental design showed more than 93 % drug release in 15 mins. Batch F9 was selected as an optimized batch from the data of overlay plot, drug release kinetics and checkpoint batch. A stability study for optimized formulation was carried out as per ICH guidelines, showed no significant changes in the evaluation parameters. Thus from the study it can be concluded that Fast Dissolving Tablets of Rasagilline mesylate formulated from solid dispersions can provide rapid drug release within a short period of time.

Keywords :

% CDR., Effervescent method, Fast Dissolving Tablets, In Vitro disintegration time, Rasagilline mesylate, solid dispersion, Solvent Evaporation Method, Wetting time

References :

  1. Prosun KG, Hemanta KS and Nayanmoni B, “Different Methods Used In Solid Dispersion.” IOSR J. Pharm. 2018, 8(7), 28-38.
  2. Mahmoud AY, “Solid Dispersion Technology, A Contemporary Overview On A Well Established Technique.” J. Pharm. Res. 2017, 2(3), 15-19.
  3. Khalid BM and Nisar AK, “Solid Dispersion: Overview of the Technology.” J. Pharm. Sci. 2017, 8(6), 2378-2387.
  4. Sangam S, Preethi S, Bharani SS and Deborose S, “A Review: Solid Dispersion, A Technique Of Solubility Enhancement.” Journal of Pharmaceutical Research. 16(1), 25-31.
  5. Shweta UK and Bakade BV, “Solid Dispersion – A Technique for Solubility Enhancement of Weakly Water Soluble Drug –A Review.” Indo j. pharm. 2014, 4(6), 2839-2484.
  6. Yanbin H and Wei GD, “Fundamental aspects of solid dispersion technology for poorly soluble drugs.” Acta Pharmaceutica Sinica B. 2014, 4(1), 18–25.
  7. Surampalli G, Sabbani PK, Nanjwade KB and Paragouda AP, “Amorphous solid dispersion method for improving oral bioavailability of poorly water-soluble drugs.” Journal of Pharmacy Research. 2013, 6, 476-480.
  8. Naveen K and Sonia P, “Dispersible Tablets: An Overview.” of Med. Pharmaceu. Allied Sci. 2019, 8(13), 2175-2191.
  9. Pooja SA, Dattatraya MS, Parag DK and Avish DM, “A Review On Fast Dissolving Drug Delivery System.” World J. Pharm. Pharmaceu. Sci. 2018, 7(7), 321-334.
  10. Rahane RD and Punit RR, “A Review on Fast Dissolving Tablet.” J.drug  ther. 2018, 8(5), 50-55.
  11. Bhavana T, “Mouth Dissolving Tablets: An Overview of Formulation Technology.” J. Infor. Res. Rev. 2018, 5(5), 5451-5459.
  12. Vaishali C, Kapil K and Deepak T, “Fast Dissolving Tablets: A Promising Approach for Drug Delivery.” J. Pharmaceu. Res. 2017, 2(4), 58-64.
  13. Santosh KR and Gautham KV, “Fast Dissolving Tablets: A Novel Approach To Enhance The Bioavailability of Poorly Soluble Drugs.” European J. Pharmaceu. Med. Res. 2017, 4(2), 274-298.
  14. Anuradha AC and Dipti HC, “Technologies evaluation and development of oro-dispersible tablet: a review.” J. Pharm. Sci. Rev. Res. 2017, 46(2), 177-183.
  15. Shehla K, Sadhana S, Santosh B and Saliya S, “Fast Dissolving Tablets: A Novel Drug Delivery System.” European J. Pharmaceu. Med. Res. 2017, 4(12), 161-172.
  16. Lovepreet S, Kapil K, Surya PG, Narinder S, Ankit V and Harjaskaran SR, “Mouth Dissolving Tablets Highlighting Innovative Techniques and Use of Natural Super disintegrant- a concise review.” Int J. Pharm. Drug. Anal. 2016, 4(5), 217-226.
  17. Abay FB and Ugurlu T, “Orally Disintegrating Tablets: A Short Review.” of Pharma. & Drug Dev. 2015, 3(3), 1-8.
  18. Ying J, Xuemei Z, Hongjie M, Hongchen H, Dongyu D, Xiuju Y and Yiyun W, “Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease.” Drug Delivery. 2018, 25(1), 143–152
  19. Reshu V, Tarun V, Charan S and Geeta S, “Matrix tablet of Rasagiline Mesylate: an approach for the treatment of parkinson disease.” Indo Am. J. P. Sci. 2017, 4(02), 284-289
  20. Viveksarathi K and Kannan K, “Formulation and Evaluation of Nanoscale Solid Lipid Particles Containing a Hydrophilic Drug-Rasagiline Mesylate.” Journal of Applied Pharmaceutical Science. 2016, 6(5), 44-50.
  21. Ravi PR, Aditya N, Patil S and Cherian L, “Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization.” Drug Deliv. 2015, 22(7), 903–910.
  22. Rama B, Kalyani P and Chintan DP, “Preparation and Evaluation of Intraoral Drug Delivery System for Rasagiline mesylate.” International Journal of Pharmaceutical Sciences and Drug Research, 2010, 2(4), 294-301
  23. Vikas V, Pankaj S, Jaya S, Lamba AK and Lamba HS, “Development, characterization and solubility study of solid dispersion of Quercetin by solvent evaporation method.” Materials Today: Proceedings. 2017, 4, 10128–10133.
  24. Jatinderpal S, Rajeev G and Ghanshyam DG, “Enhancement of Solubility of Lamotrigine by Solid Dispersion and Development of Orally Disintegrating Tablets Using 32 Full Factorial Design.” Journal of Pharmaceutics. 2015, 1-8.
  25. Yuvaraja K and Jasmina K, “Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.” JPharmaceut Biomed. 2014, 96, 10–20.
  26. Mohammad BJ, Saeed G, Khosro A, Hadi V, Siamak B, Ghobad M and Mohammad RS, “Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers.” BioImpacts, 2014, 4(3), 141-148.
  27. Madhuri SR, Ganesh TD, Tejas BD and Avinash RT, “Solubility and Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin: In Vitro, Ex Vivo, and In Vivo Studies.” Bio Med Res. Int. 2014, 1, 1-10.
  28. Pankajkumar SY, Vikas K, Udaya PS, Hans RB and Mazumder B, “Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and D-mannitol.” Saudi PharmJ. 2013, 21, 77–84.
  29. Rehab NS and Mona B, “Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation.” Powder Technology. 2013, 237, 406–414.
  30. Ritesh AF, Tarique SM, Ajay RS and Purnima DA, “Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics.” Journal of Pharmaceutics. 2013, 1, 1-15.
  31. Nemanja K, Kyriakos K, Irena H, Branka G, Zorica D and Svetlana I, “Solubility enhancement of desloratadine by solid dispersion in poloxamers.” J. Pharm. 2012, 436, 161–170.
  32. Soniya M, Atul KG and Vipin S, “Improvement in Taste and Solubility of Atenolol by Solid Dispersion System.” The Pharma Innovation. 2012, 1(8), 43-59.
  33. Bobe KR, Subrahmanya CR, Sarasija S, Gaikwad DT, Patil MD, Khade TS, Gavitre BB, Kulkarni VS and Gaikwad UT, “Formulation and Evaluation of Solid Dispersion of Atorvatstatin with Various Carriers.” Pharmacie Globale. 2011, 1(2), 1-6.
  34. Abhisekh D, Amit KN, Biswaranjan M and Satyabrata P, “Solubility and Dissolution Enhancement of Etoricoxib by Solid Dispersion Technique Using Sugar Carriers.” ISRN Pharmaceutics. 2011, 1-8.
  35. Gaurav S, Vivek KP, Garima G, Rajendra A and Giriraj TK, “Taste masking of Promethazine Hydrochloride using Eudragit E100 via solid dispersion technique to develop fast disintegrating tablets.” Der Pharmacia Lettre, 2010, 2(3), 83-94.
  36. Raghavendra KG, Prasada RM, Gopi RC, Divya K, Alekhya D and Jyoshna E, “Formulation Development and In Vitro Evaluation of Oral Disintegrating Tablets for Newer Anticonvulsant Agent.” Anal. Pharm. Res. 2019, 8(2), 85‒89.
  37. Ashok KS, Maniratna N, Rajaram R, Mohit K, Shankar LS and Mukesh S, “Formulation, Development and In-vitro Evaluation of Fast Dissolving Tablet of Aceclofenac using co-processed Superdisintegrant by Direct Compression Method.” J. Pharm. Sci. Rev. Res. 2019, 54(2), 67-72.
  38. Samvedna, Shammy J, Gaurav M, Jyotsana RM, Gaurav G, Rajendra A, Terezinha de JAP, Kamal D and Giriraj TK, “Formulation and Characterization of Oral Rapid Disintegrating Tablets of Levocetirizine.” Med. 2018, 48(1), 31–40.
  39. Rabab AH, Amr SAL, Marwa HA and Hanaa AE, “Fast disintegrating tablet of Valsartan for the treatment of pediatric hypertension: In vitro and in vivo evaluation.” J Drug Deliv Sci Tec. 2018, 43, 194–200.
  40. Dhananjay P, Sanaurrehman M, Vinod B, Abdurrahman, Awais M, Karishma S and Rajashri M, “Formulation Development and Evaluation of Famciclovir Orally Disintegrating Tablet.” Indo American J. Pharmaceu. Sci. 2018, 5(9), 8427-8439.
  41. Greeshma M, Sheri PS and Kuriachan MA, “Formulation and Evaluation of Orodispersible Tablet of Esomeprazole.” J. Pharm. Pharmaceu. Res. 2018, 12(3), 340-366.
  42. Humane SB, Shinkar DN and Saudagar RB, “Formulation and In-vitro Evaluation of Fast Disintegrating Tablet of Eprosartan Mesylate.” Biomed. Pharmaceu. Res. 2018, 7(2), 1-19.
  43. Raghavendra KG and Suresh KJN, “Formulation Development and Evaluation of Amisulpride Fast Dissolving Tablets.” FABAD J. Pharm. Sci. 2018, 43(2), 105-115.
  44. Suresh Kumar JN and Raghavendra KG, “Design, Formulation and Evaluation of Pravastatin Fast Dissolving Tablets.” Methods. 2018, 9(1), 16-23.
  45. Priya HI, Lakshmi JKS, Srinivasa RK, Manikiran SS and Rama NR, “Comparative Study of Natural and Synthetic Superdisintegrants in the Formulation of Oral Fast Disintegrating Tablets Using Levofloxacin HCl as Model Drug.” J. Pharm. Pharmaceu. Res. 2017, 10(2), 121-138.
  46. Laskshami RV, Ling SM and Sasikala C, “Effect Of Superdisintegrant On Formulation Of Mouth Dissolving Dexamethasone Tablet.” J. Res. Pharm. Sci. 2017, 8(7), 602-607.
  47. Saleh AER and Gamal AS, “Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method.” Saudi PharmJ. 2017, 25, 1086–1092.
  48. Raghavendra KG and Suresh KJN, “Formulation Development and Evaluation of Moxifloxacin.HCL Fast Dissolving Tablets.” Methods. 2017, 8(2), 160-167.
  49. Kamble SK and Shinde SS, “Design and Development of Fast Dissolving Tablet of Gliclazide.” J Develop Drugs. 2017, 6(3), 1-13.
  50. Murali Krishna GC, Kishor NK, Vijaya K and Prabandha, “Formulation, Development and In-Vitro Evaluation of Orodispersible Tablets of Lamotrigine.” World J. Pharmaceu. Life Sci. 2017, 3(3), 176-187.
  51. Darade SC, Patil PB and Kalkotwar RS, “Formulation and Evaluation of Orodispersible Tablet Containing Piroxicam by Sublimation Method.” J. Pharm. Pharmacol. 2017, 4(2), 77-82.
  52. Ayesha F and Sirisha M, “Formulation and Evaluation of Mouth Dissolving Tablets of Amiodarone (I.P).” World J. Pharm. Pharmaceu. Sci. 2017, 6(9), 1054-1070.
  53. Sravani S and Sailaja P, “Formulation and Evaluation of Fast Dissolving Tablets of Felodipine.” IOSR J. of Pharm. 2016, 6(7), 104-112.
  54. Jitender M, Parveen C and Pawan J, “Development and Evaluation of Oral Fast Dissolving Tablets of Lornoxicam using Superdisintegrants – A Comparative Study.” The Pharm. Innov. J. 2016, 5(7), 1-7.
  55. Preeti P, Ganarajan G and Preeti K, “Formulation and Evaluation of Mouth Dissolving Tablet of Telmisartan Using Natural Superdisintegrants.” Indo American J. Pharmaceu. Sci. 2016, 3(7), 713-727.
  56. Hardenia S, Darwhekar GN and Singh RP, “Optimization of Fast Dissolving Tablets of Promethazine Theoclate with Effervescent Technology Using 32 Full Factorial Design.” Int. J. Pharmaceut. Sci. Res. 2016, 7(12), 5115-5124.
  57. Priyanka S, Abhay KV, Shahnawaz K and Arun KS, “Formulation & Comparative Evaluation of Rapid Disintegrating Tablets of Diclofenac Sodium Using Sodium Starch Glycolate as A Synthetic Superdisintegrant.” World J. Pharm. Pharmaceu. Sci. 2016, 5(1), 1003-1011.
  58. Chinmaya KS, Nalini KS, Madhusmita S, Alok KM and Deepak S, “Formulation and Evaluation of Orodispersible Tablets of Granisetron Hydrochloride Using Agar as Natural Super disintegrants.” Methods. 2016, 7(1), 17-22.
  59. Indrayani DR, Pallavi M, Dipak M, Mohite SK and Magdum CS, “Design and Characterization of Fast Dissolving Tablets of Valsartan Using Synthetic and Natural Superdisintegrants.” J. Adv. Res. 2015, 3(3), 1207-1212.
  60. Uppala L and Pranusha P, “Development and Evaluation of Fast Disintegrating Tablets of Ondansetron with Natural and Synthetic Super Disintegrating Agents.” SOJ Pharm. Pharmaceu. Sci. 2015, 2(3), 1-7.
  61. Navneet KV, Shivendra PS, Abhay PS, Praveen KR and Reena S, “Formulation and Characterization of Fast Dissolving Tablet of Domperidone.” Pharmacia. Sinica. 2015, 6(9), 21-28.
  62. Singh J, Walia M and Harikumar S, “Formulation and Evaluation of Fast Dissolving Tablets of Rosuvastatin.” Drug Del. Therap. 2014, 4(5), 173-181.
  63. Deepak Sharma, “Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders.” ISRN Pharmaceutics. 2013, 1-8.
  64. Shiv G, Ajay P, Prateek P, Sanket T, Deepu P, Pramod S, Sohanlal C and Shubhangi C, “Formulation and Evaluation of Fast Dissolving Tablet of Ziprasidone HCl.” Indo American J. Pharmaceu. Res. 2013, 3(5), 3642-3651.
  65. Inayat BP, Prakash RS, Pritish K, “Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique.” Pharm. Res. 2013, 6, 593-598.
  66. Vijetha KA, Padmaja B, Sravan KG, Swetha JH, Sravanthi P and Sravanthi D, “Formulation and Characterization of Fast Dissolving Tablets of Isradipine By Using Different Technologies.” J. Pharmaceu. Res. Biomed. Anal. 2012, 1(2), 1-10.
  67. Harish C, Sachin K and Bineeta B, “Formulation and evaluation of fast dissolving tablet of Ramipril.” Pharmacia. Sinica. 2011, 2(6), 163-170.

How to Cite :

Development and Characterization of Solid Dispersion of Rasagilline Mesylate for Improvement of Dissolution Rate Using Hydrophilic Carriers. Ravi V. Patel, Gazala Y. Ansari, Jitendra O. Bhangale , 6(6), 3223-3239. Retrieved from https://ijcsrr.org/single-view/?id=10607&pid=10500

Most read articles by the same author(s)

Ravi V. Patel, Gazala Y. Ansari, Jitendra O. Bhangale,

View

183

Citation

Downloads

Article Details